Group One Trading
MRNA icon

Group One Trading’s Moderna MRNA Stock Holding History

Group One Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6M Sell
445,100
-30,200
-6% -$1.41M 0.04% 426
2025
Q4 		$14M Sell
475,300
-72,600
-13% -$1.97M 0.02% 739
2025
Q3 		$14.2M Buy
547,900
+138,600
+34% +$3.87M 0.02% 697
2025
Q2 		$11.3M Sell
409,300
-16,900
-4% -$445K 0.03% 735
2025
Q1 		$12.1M Buy
426,200
+151,700
+55% +$5.38M 0.04% 541
2024
Q4 		$11.4M Sell
274,500
-61,400
-18% -$2.93M 0.03% 628
2024
Q3 		$22.4M Buy
335,900
+172,100
+105% +$15.8M 0.06% 245
2024
Q2 		$19.5M Buy
163,800
+46,900
+40% +$5.94M 0.08% 210
2024
Q1 		$12.5M Buy
116,900
+1,200
+1% +$121K 0.05% 349
2023
Q4 		$11.5M Sell
115,700
-62,500
-35% -$5.26M 0.03% 623
2023
Q3 		$18.4M Sell
178,200
-42,500
-19% -$4.74M 0.06% 257
2023
Q2 		$26.8M Buy
220,700
+48,400
+28% +$6.46M 0.09% 164
2023
Q1 		$26.5M Sell
172,300
-473,200
-73% -$78.1M 0.1% 154
2022
Q4 		$116M Buy
645,500
+170,100
+36% +$27.8M 0.27% 47
2022
Q3 		$56.2M Sell
475,400
-288,100
-38% -$43.7M 0.11% 119
2022
Q2 		$109M Sell
763,500
-338,200
-31% -$48.3M 0.17% 62
2022
Q1 		$190M Sell
1,101,700
-214,100
-16% -$36M 0.19% 53
2021
Q4 		$334M Sell
1,315,800
-266,200
-17% -$77.8M 0.27% 36
2021
Q3 		$609M Buy
1,582,000
+774,100
+96% +$285M 0.66% 12
2021
Q2 		$190M Buy
807,900
+77,100
+11% +$13.8M 0.23% 49
2021
Q1 		$95.7M Sell
730,800
-11,900
-2% -$1.72M 0.14% 95
2020
Q4 		$77.6M Buy
742,700
+102,100
+16% +$10.3M 0.13% 100
2020
Q3 		$45.3M Buy
640,600
+167,800
+35% +$11.7M 0.14% 107
2020
Q2 		$30.4M Sell
472,800
-239,700
-34% -$13.1M 0.14% 128
2020
Q1 		$21.3M Buy
712,500
+579,900
+437% +$13.3M 0.17% 88
2019
Q4 		$2.59M Sell
132,600
-14,600
-10% -$259K 0.02% 1095
2019
Q3 		$2.34M Buy
147,200
+78,400
+114% +$1.16M 0.02% 1084
2019
Q2 		$1.01M Buy
68,800
+67,000
+3,722% +$1.44M 0.01% 1586
2019
Q1 		$37K Buy
+1,800
New +$33.4K ﹤0.01% 3720

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's MRNA Position: Q1 2026 in Review

Group One Trading reduced its Moderna (MRNA) stake by 75% in Q1 2026, selling an estimated $6.63M and leaving 47,901 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Group One Trading first reported a position in MRNA in Q4 2018 and has held it in 25 quarters since. The position peaked at $37.3M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Group One Trading held 47,901 shares of Moderna worth $2.43M as of Q1 2026.
  • Group One Trading sold 142,054 Moderna shares in Q1 2026, an estimated $6.63M.
  • Moderna made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #1902 holding.
  • Group One Trading first reported a position in Moderna in Q4 2018 and has held it in 25 quarters since.
  • Group One Trading's Moderna position peaked at $37.3M in Q4 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.